Psychiatric Times April 19, 2024
Psychedelics: it is time to integrate this treatment option into clinical care while holding fast to the principles of medical ethics.
COMMENTARY
The resurgence of psychedelics in public discourse and their therapeutic potential for a wide range of mental health conditions has sparked renewed interest among various populations.1 This revival, accompanied by legislative movements towards decriminalization and the establishment of regulated programs for substances like psilocybin, highlights the increasing accessibility of these substances beyond traditional medical settings.2 The societal and legal shifts towards acceptance of psychedelics require health care providers, especially psychiatrists, to integrate these changes with the steadfast principles of medical ethics.
Psychiatrists, who are more likely to encounter patients who are interested in or already using psychedelics,2 may...
Today's Sponsors
Today's Sponsor